Board appointment at Bionovo
This article was originally published in Scrip
Executive Summary
Bionovo, a US-based pharmaceutical company focused on the discovery and development of treatments for women's health and cancer, has elected Dr James Pickar to its medical advisory board. Dr Pickar, who has more than 25 years' clinical research experience, served as assistant vice-president of clinical R&D at Wyeth Research. He is currently an adjunct associate professor of obstetrics and gynaecology at Columbia University, and has served on the board of directors for the International Menopause Society since 2005.